Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7952078 | 0.88 | TSHR (0.46) | TSHRALDH1A1TDP1 | |
| SCHEMBL11070616 | 0.80 | TSHR (0.50) | TSHRALDH1A1TDP1 | |
| SCHEMBL8680521 | 0.80 | LMNA (0.43) | — | |
| SCHEMBL9302609 | 0.74 | — | — | |
| SCHEMBL24196133 | 0.73 | TSHR (0.50) | TSHRALDH1A1TDP1 | |
| SCHEMBL18756386 | 0.73 | — | — | |
| SCHEMBL24667370 | 0.73 | TSHR (0.50) | TSHRALDH1A1TDP1 | |
| SCHEMBL26318514 | 0.73 | — | — | |
| SCHEMBL23049074 | 0.73 | TSHR (0.33) | TSHR | |
| SCHEMBL18681323 | 0.73 | DNM1 (0.36) | TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1413570-B1 | 5,7,7-Trimethyloctanenitrile | SYMRISE GMBH & CO KG (DE) | 2006-05-10 | — | — | EP | claimed |
| US-6998378-B2 | 5,7,7-trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2006-02-14 | — | — | US | claimed |
| US-20040127394-A1 | 5,7,7-Trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2004-07-01 | — | — | US | claimed |
| EP-1413570-A1 | 5,7,7-Trimethyloctanenitrile | Symrise GmbH & Co. KG (DE) | 2004-04-28 | — | — | EP | claimed |
| EP-3612620-B1 | 4-ETHYL-OCTENE-2/3-NITRILE AS A FRAGRANCE | SYMRISE AG (DE) | 2021-03-03 | — | — | EP | disclosed |
| EP-1413570-B1 | 5,7,7-Trimethyloctanenitrile | SYMRISE GMBH & CO KG (DE) | 2006-05-10 | — | — | EP | disclosed |
| EP-1413570-B1 | 5,7,7-Trimethyloctanenitrile | SYMRISE GMBH & CO KG (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-6998378-B2 | 5,7,7-trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2006-02-14 | — | — | US | disclosed |
| US-6998378-B2 | 5,7,7-trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2006-02-14 | — | — | US | disclosed |
| US-6998378-B2 | 5,7,7-trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2006-02-14 | — | — | US | disclosed |
| US-20040127394-A1 | 5,7,7-Trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2004-07-01 | — | — | US | disclosed |
| US-20040127394-A1 | 5,7,7-Trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2004-07-01 | — | — | US | disclosed |
| US-20040127394-A1 | 5,7,7-Trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2004-07-01 | — | — | US | disclosed |
| CN-1502603-A | 5,7,7-trimethyloctanenitrile | ˹��ϣķ | 2004-06-09 | — | — | CN | disclosed |
| CN-1502603-A | 5,7,7-trimethyloctanenitrile | ˹��ϣķ | 2004-06-09 | — | — | CN | disclosed |
| JP-2004137275-A | 5,7,7-TRIMETHYLOCTANENITRILE | SYMRISE GMBH & CO KG | 2004-05-13 | — | — | JP | disclosed |
| EP-1413570-A1 | 5,7,7-Trimethyloctanenitrile | Symrise GmbH & Co. KG (DE) | 2004-04-28 | — | — | EP | disclosed |
| EP-1413570-A1 | 5,7,7-Trimethyloctanenitrile | Symrise GmbH & Co. KG (DE) | 2004-04-28 | — | — | EP | disclosed |
| EP-1413570-A1 | 5,7,7-Trimethyloctanenitrile | Symrise GmbH & Co. KG (DE) | 2004-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127394-A1 | 5,7,7-Trimethyloctannitril | API5, TAS2R5, TAAR5 | TSHR 4490/4885ALDH1A1 380/4885TDP1 4054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.